Quantum BioPharma Ltd. Cash Flows From Used In Operating Activities
Quantum BioPharma Ltd. (QNTM) reported Cash Flows From Used In Operating Activities of -$8.24 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:CashFlowsFromUsedInOperatingActivities · last filed 2026-03-26
CAD
| Period end | Cash Flows From Used In Operating Activities 12 month |
|---|---|
| 2019-12-31 | -18.23M CAD 40-F/A · filed 2020-03-17 |
| 2018-12-31 | -18.49M CAD 40-F/A · filed 2020-03-17 |
USD
| Period end | Cash Flows From Used In Operating Activities 3 month | Cash Flows From Used In Operating Activities 6 month | Cash Flows From Used In Operating Activities 9 month | Cash Flows From Used In Operating Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$305.60K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | -$2.03M derived: sum of 2 quarters · filed 2026-03-26 | -$3.98M derived: sum of 3 quarters · filed 2026-03-26 | -$8.24M 20-F · filed 2026-03-26 |
| 2025-09-30 | -$1.72M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | -$3.67M derived: sum of 2 quarters · filed 2025-11-06 | -$7.93M 6-K · filed 2025-11-06 | -$8.77M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-06-30 | -$1.95M derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | -$6.21M 6-K · filed 2025-08-07 | -$7.05M derived: sum of 3 quarters · filed 2026-03-26 | -$10.51M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-03-31 | -$4.26M 6-K/A · filed 2025-06-16 | -$5.10M derived: sum of 2 quarters · filed 2026-03-26 | -$8.56M derived: sum of 3 quarters · filed 2026-03-26 | -$9.16M derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-12-31 | -$835.76K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | -$4.30M derived: sum of 2 quarters · filed 2026-03-26 | -$4.90M derived: sum of 3 quarters · filed 2026-03-26 | -$6.88M 20-F · filed 2026-03-26 |
| 2024-09-30 | -$3.46M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | -$4.07M derived: sum of 2 quarters · filed 2025-11-06 | -$6.04M 6-K · filed 2025-11-06 | -$6.89M derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-06-30 | -$606.48K derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | -$2.58M 6-K · filed 2025-08-07 | -$3.43M derived: sum of 3 quarters · filed 2026-03-26 | -$5.14M derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-03-31 | -$1.97M 6-K/A · filed 2025-06-16 | -$2.83M derived: sum of 2 quarters · filed 2026-03-26 | -$4.54M derived: sum of 3 quarters · filed 2026-03-26 | |
| 2023-12-31 | -$851.65K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | -$2.56M derived: sum of 2 quarters · filed 2026-03-26 | -$10.83M 20-F · filed 2026-03-26 | |
| 2023-09-30 | -$1.71M derived: 6-K 9 month − 6-K/A 6 month · filed 2024-11-12 | -$9.98M 6-K · filed 2024-11-12 | ||
| 2023-06-30 | -$8.26M 6-K/A · filed 2024-08-19 | |||
| 2022-12-31 | -$28.33M 20-F/A · filed 2025-03-31 | |||
| 2021-12-31 | -$20.75M 20-F · filed 2024-04-02 | |||
| 2020-12-31 | -$19.13M 20-F · filed 2023-03-31 | |||
| 2019-12-31 | -$13.71M 40-F · filed 2021-03-17 |